tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

PHVS Stock Latest News

Pharvaris initiated with a Buy at JonesResearch
The FlyPharvaris initiated with a Buy at JonesResearch
2d ago
PHVS
Oppenheimer healthcare analysts hold an analyst/industry conference call
PremiumThe Fly
Oppenheimer healthcare analysts hold an analyst/industry conference call
5d ago
PHVS
Pharvaris price target raised to $42 from $38 at Oppenheimer
PremiumThe Fly
Pharvaris price target raised to $42 from $38 at Oppenheimer
15d ago
PHVS
Pharvaris Reveals Positive HAE Drug Data
PremiumCompany Announcements
Pharvaris Reveals Positive HAE Drug Data
16d ago
6K
PHVS
Pharvaris’ deucrictibant shows safety and tolerability in Phase 2 HAE study
PremiumThe Fly
Pharvaris’ deucrictibant shows safety and tolerability in Phase 2 HAE study
16d ago
PHVS
Pharvaris provides business update, expands deucrictibant development program
PremiumThe FlyPharvaris provides business update, expands deucrictibant development program
16d ago
PHVS
Pharvaris Presents Data at the Bradykinin Symposium 2024
Premium
Press Releases
Pharvaris Presents Data at the Bradykinin Symposium 2024
16d ago
PHVS
Pharvaris Presents Deucrictibant Long-Term Extension Data for Both the Prophylactic and On-Demand Treatment of HAE at the Bradykinin Symposium 2024
Premium
Press Releases
Pharvaris Presents Deucrictibant Long-Term Extension Data for Both the Prophylactic and On-Demand Treatment of HAE at the Bradykinin Symposium 2024
16d ago
PHVS
Pharvaris Provides Business Update and Expands Development Program for Deucrictibant
PremiumPress Releases
Pharvaris Provides Business Update and Expands Development Program for Deucrictibant
16d ago
PHVS
Deucrictibant Clinical, Real-World, Nonclinical, and Discovery Data to be Presented at the Bradykinin Symposium
PremiumPress Releases
Deucrictibant Clinical, Real-World, Nonclinical, and Discovery Data to be Presented at the Bradykinin Symposium
24d ago
PHVS
Pharvaris Advances HAE Treatment Trials
PremiumCompany Announcements
Pharvaris Advances HAE Treatment Trials
1M ago
6K
PHVS
Pharvaris Reports Second Quarter 2024 Financial Results and Provides Business Update
PremiumPress Releases
Pharvaris Reports Second Quarter 2024 Financial Results and Provides Business Update
1M ago
PHVS
Wedbush reveals three potential buyout targets for Biogen
PremiumThe FlyWedbush reveals three potential buyout targets for Biogen
2M ago
BIIB
EWTX
3 Best Stocks to Buy Now, 7/4/2024, According to Top Analysts
Premium
Market News
3 Best Stocks to Buy Now, 7/4/2024, According to Top Analysts
3M ago
VET
LEGN
Pharvaris price target raised to $38 from $36 at Oppenheimer
Premium
The Fly
Pharvaris price target raised to $38 from $36 at Oppenheimer
3M ago
PHVS
Pharvaris Shareholders Approve Key Resolutions
PremiumCompany Announcements
Pharvaris Shareholders Approve Key Resolutions
3M ago
6K
PHVS
Pharvaris Schedules 2024 Shareholder Meeting
PremiumCompany Announcements
Pharvaris Schedules 2024 Shareholder Meeting
3M ago
6K
PHVS
Pharvaris Announces Annual Meeting of Shareholders
PremiumPress Releases
Pharvaris Announces Annual Meeting of Shareholders
3M ago
PHVS
Pharvaris Showcases Promising HAE Treatment Data
PremiumCompany Announcements
Pharvaris Showcases Promising HAE Treatment Data
4M ago
6K
PHVS
Pharvaris Highlights Properties of Deucrictibant in Data Presentations at Recent Congresses
PremiumPress ReleasesPharvaris Highlights Properties of Deucrictibant in Data Presentations at Recent Congresses
4M ago
PHVS
Pharvaris’ deucrictibant shows positive results in HAE attack prevention
Premium
The Fly
Pharvaris’ deucrictibant shows positive results in HAE attack prevention
4M ago
PHVS
Pharvaris to Present Clinical and Nonclinical Data at Upcoming Congresses
Premium
Press Releases
Pharvaris to Present Clinical and Nonclinical Data at Upcoming Congresses
4M ago
PHVS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >